CN103827296B - 用于产生病毒抗原和疫苗的方法 - Google Patents

用于产生病毒抗原和疫苗的方法 Download PDF

Info

Publication number
CN103827296B
CN103827296B CN201280035724.9A CN201280035724A CN103827296B CN 103827296 B CN103827296 B CN 103827296B CN 201280035724 A CN201280035724 A CN 201280035724A CN 103827296 B CN103827296 B CN 103827296B
Authority
CN
China
Prior art keywords
virus
enveloped
viral
enveloped virus
harvest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201280035724.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN103827296A (zh
Inventor
崔以晴
王丁
王一丁
J·萨斯
R·范特霍夫
S·沙科尔
G·J·范路耶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Biologicals BV
Original Assignee
Abbott Biologicals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals BV filed Critical Abbott Biologicals BV
Publication of CN103827296A publication Critical patent/CN103827296A/zh
Application granted granted Critical
Publication of CN103827296B publication Critical patent/CN103827296B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201280035724.9A 2011-07-20 2012-07-04 用于产生病毒抗原和疫苗的方法 Expired - Fee Related CN103827296B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161509630P 2011-07-20 2011-07-20
EP11174660 2011-07-20
US61/509,630 2011-07-20
EP11174660.8 2011-07-20
PCT/EP2012/063045 WO2013010797A1 (en) 2011-07-20 2012-07-04 Process for producing viral antigen and vaccines

Publications (2)

Publication Number Publication Date
CN103827296A CN103827296A (zh) 2014-05-28
CN103827296B true CN103827296B (zh) 2016-11-16

Family

ID=45094875

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280035724.9A Expired - Fee Related CN103827296B (zh) 2011-07-20 2012-07-04 用于产生病毒抗原和疫苗的方法

Country Status (12)

Country Link
EP (1) EP2734619B1 (enExample)
JP (1) JP6275641B2 (enExample)
KR (2) KR20160096215A (enExample)
CN (1) CN103827296B (enExample)
AU (1) AU2012286098C1 (enExample)
BR (1) BR112014001049A2 (enExample)
CA (1) CA2841604C (enExample)
ES (1) ES2653197T3 (enExample)
MX (1) MX2014000753A (enExample)
RU (1) RU2565827C2 (enExample)
TW (1) TW201311896A (enExample)
WO (1) WO2013010797A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524563A (zh) * 2014-12-12 2015-04-22 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
WO2019121846A1 (en) 2017-12-19 2019-06-27 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
JP7360594B2 (ja) * 2017-12-28 2023-10-13 共立製薬株式会社 ワクチン製剤、並びに魚類のイリドウイルス感染症予防方法
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
KR102714626B1 (ko) 2018-06-12 2024-10-08 케이바이오 홀딩스 리미티드 바이러스 및 항원 정제 및 접합
CN112384615A (zh) * 2018-07-04 2021-02-19 普罗拜奥根股份公司 用于纯化包膜病毒的方法
PE20211140A1 (es) 2018-11-15 2021-06-25 Bayer Healthcare Llc Metodos de inactivacion virica para la fabricacion continua de anticuerpos
RU2710239C1 (ru) * 2019-06-14 2019-12-25 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
AU2020380604A1 (en) * 2019-11-07 2022-06-09 Seqirus UK Limited Compositions and methods for producing a viral vaccine with reduced particle size
US20230212230A1 (en) * 2020-04-29 2023-07-06 Sk Bioscience Co., Ltd. Influenza virus production method using single-use culture process system and rapid confirmation test of influenza virus antigen purification condition
KR102546626B1 (ko) * 2020-04-29 2023-06-21 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
WO2009115917A2 (en) * 2008-03-18 2009-09-24 Novartis Ag Improvements in preparation of influenza virus vaccine antigens
WO2010036760A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
WO2010036774A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses
CN101790381A (zh) * 2007-08-28 2010-07-28 巴克斯特国际公司 生产病毒疫苗的方法
CN101804202A (zh) * 2003-02-25 2010-08-18 米迪缪尼有限公司 制备流感疫苗组合物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240762A (en) * 1979-03-12 1980-12-23 Johnston Pump Company Seal-aligning rigid coupling assembly
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
RU2283139C1 (ru) * 2005-03-21 2006-09-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения антигенов для вакцины против вирусов гриппа
EP1982727A1 (en) * 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
CN101804202A (zh) * 2003-02-25 2010-08-18 米迪缪尼有限公司 制备流感疫苗组合物的方法
CN101790381A (zh) * 2007-08-28 2010-07-28 巴克斯特国际公司 生产病毒疫苗的方法
WO2009115917A2 (en) * 2008-03-18 2009-09-24 Novartis Ag Improvements in preparation of influenza virus vaccine antigens
CN101998990A (zh) * 2008-03-18 2011-03-30 诺华有限公司 流感病毒疫苗抗原制备方法的改进
WO2010036760A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
WO2010036774A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses

Also Published As

Publication number Publication date
KR20140038530A (ko) 2014-03-28
CN103827296A (zh) 2014-05-28
RU2565827C2 (ru) 2015-10-20
BR112014001049A2 (pt) 2017-02-21
AU2012286098C1 (en) 2016-09-15
RU2014101484A (ru) 2015-07-27
JP2014524747A (ja) 2014-09-25
CA2841604C (en) 2020-01-21
TW201311896A (zh) 2013-03-16
EP2734619A1 (en) 2014-05-28
EP2734619B1 (en) 2017-09-06
KR20160096215A (ko) 2016-08-12
WO2013010797A1 (en) 2013-01-24
AU2012286098A1 (en) 2014-01-23
JP6275641B2 (ja) 2018-02-07
ES2653197T3 (es) 2018-02-06
CA2841604A1 (en) 2013-01-24
MX2014000753A (es) 2014-05-07

Similar Documents

Publication Publication Date Title
CN103827296B (zh) 用于产生病毒抗原和疫苗的方法
AU2012286098B2 (en) Process for producing viral antigen and vaccines
US10329536B2 (en) Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture
JP5264843B2 (ja) 細胞培養におけるインフルエンザウイルスの複製の方法、および本方法によって入手可能なインフルエンザウイルス
CZ297492B6 (cs) Způsob přípravy povrchových antigenních proteinů z virů chřipky a vakcína na bázi těchtoproteinů
CN104862267A (zh) 适应于无血清培养和悬浮培养的mdck来源的细胞系与利用该细胞制备疫苗病毒的方法
JP2018511347A (ja) ウイルス用無菌精製プロセス
JP2012507272A (ja) 新規な方法
US11999975B2 (en) Method for purifying an enveloped virus
CN105473712B (zh) 在细胞培养物中大规模生产病毒
KR20110092280A (ko) ｐＨ에 안정한 외피보유 바이러스의 생산 방법
JP7779858B2 (ja) 使い捨て培養工程システムを用いたインフルエンザウイルス生産方法及びインフルエンザウイルス抗原精製条件の迅速確認試験
HK1194763A (en) Process for producing viral antigen and vaccines
KR101581228B1 (ko) 바이러스의 증식을 위한 ２-단계 온도 프로파일
KR101862332B1 (ko) 인플루엔자 전바이러스 백신 제조 방법
KR102444684B1 (ko) 일회용 배양 공정 시스템을 이용한 인플루엔자 바이러스 생산 방법
Weigel Development of chromatography-based purification processes for cell culture-derived influenza virus particles
US20230220356A1 (en) Compositions and methods for producing a viral vaccine with reduced particle size
KR20210133732A (ko) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
HK1010833B (en) Influenza vaccine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1194763

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20161116

Termination date: 20170704

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1194763

Country of ref document: HK